1. In Vivo
  2. >>Growth

TechBio’s Next Wave: Where AI Meets Biology And Investment Opportunity

 
• By David Wild

TechBio stands at a critical inflection point, where computational innovation meets the reality of biopharma. Industry leaders have begun to cut through the hype and identify where sustainable value truly lies in this rapidly evolving landscape.

Biotech Showcase TechBio Panel
From L to R: Michael Sarshad, Chris Benko, Navjeewan Khosla, Celestine Schnugg, Ben Vandendriessche and Brent Vaughan (Photo Credit: Scott Chernis)
Key Takeaways
  • Investors are placing a premium on the assets of TechBio companies, rather than just their platforms, pushing founders to prove how their AI technologies can supercharge therapeutic development and drive down costs.
  • The next frontier in AI-driven drug development involves specialized foundational models built on curated datasets that address specific biological questions

Seasoned investors are increasingly distinguishing between flashy AI technologies and those that meaningfully accelerate

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Growth

More from VC Playbook

Podcast: Improving Communication – The Relationship Between Biotech And Pharma

 
• By David Wild

Ali Pashazadeh, CEO, chair and founder of Treehill Partners discusses the need for increased communication between biotech and biopharma. 

Investing Is A People Business, Says LifeArc’s Clare Terlouw

 
• By Ashley Yeo

Success in life sciences venture funding requires drive and speed, says In Vivo Rising Leader, Clare Terlouw. But there is more to it than that.  

Advice From Investors On Early-Stage Financing

 
• By David Wild

Startup financing may be hard to come by, but now is not the time to ask for less cash.